PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. - Valentine WJ; Bottomley JM; Palmer AJ; Brändle M; Foos V; Williams R; Dormandy JA; Yates J; Tan MH; Massi-Benedetti M; PROactive Study Group (Diabetic Medicine, 2007)